focus -WSS

focus

author：entertainment 2025-10-01 23:08:20 Page View：434

Judge's gavel — Legal experts unpacked the pharmaceutical industry's scattershot approach to challenging Medicare's new power to negotiate drug prices. Adobe

WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Readout Newsletter: Bristol, Sangamo, Gilead, and more
Next article： Drug repurposing or repositioning? The language matters

explore

How one medical school became remarkably diverse

ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

RaDonda Vaught links Vanderbilt hospital issues to patient death

RaDondaVaughtsitsinacourtroomaheadofhersentencinginNashville,Tenn.,onFriday,May13,2022.NicoleHester/

Jerome Adams on the need for new antivirals for Covid

PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

Methadone treatment changes are coming. Do they go far enough?

AdoseofmethadoneKevinD.Liles/APThefederalgovernmentisreformingmethadonecareforthefirsttimeinovertwod

focus

leisure time

explore

Methadone treatment changes are coming. Do they go far enough?